← Back to patent-cliff list
CAS 101328-85-2
(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one
Codes: LEVOS-002
Application context (from source-drug indications)
Heart failureLevosimendanPulmonary arterial hypertensionLevosimendan心肌炎LevosimendanPulmonary hypertensionLevosimendanLeft ventricular dysfunctionLevosimendanSubarachnoid haemorrhageLevosimendan
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Levosimendan | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one→(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one→malononitrile
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.